Platelet aggregation: Involvement of thrombin and fibrin(ogen)

Frontiers in Bioscience

Volumn 10, Issue SUPPL. 2, 2005, Pages 2504-2517

  Lisman, Ton ^a   Weeterings, Cees ^b   De Groot, Philip G ^b  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b NONE

Author keywords

Fibrin; Fibrinogen; Glycoprotein Ib; Platelet; Protease Activated Receptor; Review; Thrombin

Indexed keywords

ALPHA INTEGRIN; ANTICOAGULANT AGENT; FIBRIN; FIBRINOGEN; GLYCOPROTEIN IB; PROTEIN TYROSINE KINASE; PROTEINASE ACTIVATED RECEPTOR; PROTEINASE ACTIVATED RECEPTOR 1; PROTEINASE ACTIVATED RECEPTOR 2; PROTEINASE ACTIVATED RECEPTOR 3; RECEPTOR; THROMBIN; THROMBIN INHIBITOR;

ACTIN FILAMENT; ANTICOAGULATION; ARTICLE; CHEMICAL BOND; CRYSTAL STRUCTURE; ENZYME LINKED IMMUNOSORBENT ASSAY; ENZYME SPECIFICITY; FIBRINOGEN METABOLISM; FIBRINOGEN SYNTHESIS; HEMOSTASIS; HUMAN; MOLECULAR CLONING; PROGNOSIS; PROTEIN DEGRADATION; THERAPY; THROMBOCYTE; THROMBOCYTE ACTIVATION; THROMBOCYTE ADHESION; THROMBOCYTE AGGLUTINATION; THROMBOCYTE AGGREGATION; THROMBOCYTE AGGREGATION INHIBITION; THROMBOCYTE RELEASE REACTION; THROMBOGENESIS; THROMBOSIS;

EID: 21344463591     PISSN: 27686701     EISSN: 27686698     Source Type: Journal    
DOI: 10.2741/1715     Document Type: Article

References (99)

1. Vu TK, DT Hung, VI Wheaton, SR Coughlin: Molecular cloning of a functional thrombin receptor reveals a novel proteolytic mechanism of receptor activation. Cell. 64, 1057-1068 (1991)
2. Ishihara H, AJ Connolly, D Zeng, ML Kahn, YW Zheng, C Timmons, T Tram, SR Coughlin: Protease-activated receptor 3 is a second thrombin receptor in humans. Nature. 386, 502-506 (1997)
3. Xu WF, H Andersen, TE Whitmore, SR Presnell, DP Yee, A Ching, T Gilbert, EW Davie, DC Foster: Cloning and characterization of human protease-activated receptor 4. Proc Natl Acad Sci U S A. 95, 6642-6646 (1998)
4. Nystedt S, K Emilsson, AK Larsson, B Strombeck, J Sundelin: Molecular cloning and functional expression of the gene encoding the human proteinase-activated receptor 2. Eur J Biochem. 232, 84-89 (1995)
5. Molino M, ES Barnathan, R Numerof, J Clark, M Dreyer, A Cumashi, JA Hoxie, N Schechter, M Woolkalis, LF Brass: Interactions of mast cell tryptase with thrombin receptors and PAR-2. J Biol Chem. 272, 4043-4049 (1997)
6. Camerer E, W Huang, SR Coughlin: Tissue factor- and factor X-dependent activation of protease-activated receptor 2 by factor VIIa. Proc Natl Acad Sci U S A. 97, 5255-5260 (2000)
7. Kahn ML, M Nakanishi-Matsui, MJ Shapiro, H Ishihara, SR Coughlin: Protease-activated receptors 1 and 4 mediate activation of human platelets by thrombin. J Clin Invest. 103, 879-887 (1999)
8. Ishii K, R Gerszten, YW Zheng, JB Welsh, CW Turck, SR Coughlin: Determinants of thrombin receptor cleavage. Receptor domains involved, specificity, and role of the P3 aspartate. J Biol Chem. 270, 16435-16440 (1995)
9. De Candia E, SW Hall, S Rutella, R Landolfi, RK Andrews, R De Cristofaro: Binding of thrombin to glycoprotein Ib accelerates the hydrolysis of Par-1 on intact platelets. J Biol Chem. 276, 4692-4698 (2001)
10. Adam F, TJ Verbeuren, JL Fauchere, MC Guillin, M Jandrot-Perrus: Thrombin-induced platelet PAR4 activation: role of glycoprotein Ib and ADP. J Thromb Haemost. 1, 798-804 (2003)
11. Coughlin SR: Thrombin signalling and protease-activated receptors. Nature. 407, 258-264 (2000)
12. Kim S, C Foster, A Lecchi, TM Quinton, DM Prosser, J Jin, M Cattaneo, SP Kunapuli: Protease-activated receptors 1 and 4 do not stimulate G(i) signaling pathways in the absence of secreted ADP and cause human platelet aggregation independently of G(i) signaling. Blood. 99, 3629-3636 (2002)
13. Macfarlane SR, MJ Seatter, T Kanke, GD Hunter, R Plevin: Proteinase-activated receptors. Pharmacol Rev. 53, 245-282 (2001)
14. Ishii K, L Hein, B Kobilka, SR Coughlin: Kinetics of thrombin receptor cleavage on intact cells. Relation to signaling. J Biol Chem. 268, 9780-9786 (1993)
15. Hoxie JA, M Ahuja, E Belmonte, S Pizarro, R Parton, LF Brass: Internalization and recycling of activated thrombin receptors. J Biol Chem. 268, 13756-13763 (1993)
16. Andersen H, DL Greenberg, K Fujikawa, W Xu, DW Chung, EW Davie: Protease-activated receptor 1 is the primary mediator of thrombin-stimulated platelet procoagulant activity. Proc Natl Acad Sci U S A. 96, 11189-11193 (1999)
17. Chung AW, P Jurasz, MD Hollenberg, MW Radomski: Mechanisms of action of proteinase-activated receptor agonists on human platelets. Br J Pharmacol. 135, 1123-1132 (2002)
18. Sambrano GR, W Huang, T Faruqi, S Mahrus, C Craik, SR Coughlin: Cathepsin G activates protease-activated receptor-4 in human platelets. J Biol Chem. 275, 6819-6823 (2000)
19. Quinton TM, S Kim, CK Derian, J Jin, SP Kunapuli: Plasmin-mediated activation of platelets occurs by cleavage of protease-activated receptor 4. J Biol Chem. 279, 18434-18439 (2004)
20. Kahn ML, YW Zheng, W Huang, V Bigornia, D Zeng, S Moff, RV Farese, Jr., C Tam, SR Coughlin: A dual thrombin receptor system for platelet activation. Nature. 394, 690-694 (1998)
21. Weiss EJ, JR Hamilton, KE Lease, SR Coughlin: Protection against thrombosis in mice lacking PAR3. Blood. 100, 3240-3244 (2002)
22. Levine MN, G Raskob, S Landefeld, C Kearon: Hemorrhagic complications of anticoagulant treatment. Chest. 119, 1088-1218 (2001)
23. Selnick HG, JC Barrow, PG Nantermet, TM Connolly: Non-peptidic small-molecule antagonists of the human platelet thrombin receptor PAR-1. Curr Med Chem Cardiovasc Hematol Agents. 1, 47-59 (2003)
24. Damiano BP, CK Derian, BE Maryanoff, HC Zhang, PA Gordon: RWJ-58259: a selective antagonist of protease activated receptor-1. Cardiovasc Drug Rev. 21, 313-326 (2003)
25. Ahn HS, S Chackalamannil, G Boykow, MP Graziano, C Foster: Development of proteinase-activated receptor 1 antagonists as therapeutic agents for thrombosis, restenosis and inflammatory diseases. Curr Pharm Des. 9, 2349-2365 (2003)
26. Derian CK, BP Damiano, MF Addo, AL Darrow, MR D'Andrea, M Nedelman, HC Zhang, BE Maryanoff, P Andrade-Gordon: Blockade of the thrombin receptor protease-activated receptor-1 with a small-molecule antagonist prevents thrombus formation and vascular occlusion in nonhuman primates. J Pharmacol Exp Ther. 304, 855-861 (2003)
27. Andrade-Gordon P, CK Derian, BE Maryanoff, HC Zhang, MF Addo, W Cheung, BP Damiano, MR D'Andrea, AL Darrow, L de Garavilla, AJ Eckardt, EC Giardino, BJ Haertlein, DF McComsey: Administration of a potent antagonist of protease-activated receptor-1 (PAR-1) attenuates vascular restenosis following balloon angioplasty in rats. J Pharmacol Exp Ther. 298, 34-42 (2001)
28. Okumura T, M Hasitz, GA Jamieson: Platelet glycocalicin. Interaction with thrombin and role as thrombin receptor of the platelet surface. J Biol Chem. 253, 3435-3443 (1978)
29. Jamieson GA & T Okumura: Reduced thrombin binding and aggregation in Bernard-Soulier platelets. J Clin Invest. 61, 861-864 (1978)
30. Modderman PW, LG Admiraal, A Sonnenberg, AE dem Borne: Glycoproteins V and Ib-IX form a noncovalent complex in the platelet membrane. J Biol Chem. 267, 364-369 (1992)
31. Marchese P, M Murata, M Mazzucato, P Pradella, L De Marco, J Ware, ZM Ruggeri: Identification of three tyrosine residues of glycoprotein Ib alpha with distinct roles in von Willebrand factor and alpha-thrombin binding. J Biol Chem. 270, 9571-9578 (1995)
32. De Marco L, M Mazzucato, A Masotti, JW Fenton, ZM Ruggeri: Function of glycoprotein Ib alpha in platelet activation induced by alpha-thrombin. J Biol Chem. 266, 23776-23783 (1991)
33. Shrimpton CN, G Borthakur, S Larrucea, MA Cruz, JF Dong, JA Lopez: Localization of the adhesion receptor glycoprotein Ib-DC-V complex to lipid rafts is required for platelet adhesion and activation. J Exp Med. 196, 1057-1066 (2002)
34. Baglia FA, CN Shrimpton, JA Lopez, PN Walsh: The glycoprotein Ib-DC-V complex mediates localization of factor XI to lipid rafts on the platelet membrane. J Biol Chem. 278, 21744-21750 (2003)
35. Li CQ, A Vindigni, JE Sadler, MR Wardell: Platelet glycoprotein Ib alpha binds to thrombin anion-binding exosite II inducing allosteric changes in the activity of thrombin. J Biol Chem. 276, 6161-6168 (2001)
36. De Cristofaro R, E De Candia, R Landolfi, S Rutella, SW Hall: Structural and functional mapping of the thrombin domain involved in the binding to the platelet glycoprotein Ib. Biochemistry. 40, 13268-13273 (2001)
37. Celikel R, RA McClintock, JR Roberts, GL Mendolicchio, J Ware, KI Varughese, ZM Ruggeri: Modulation of alpha-thrombin function by distinct interactions with platelet glycoprotein Ibalpha. Science. 301, 218-221 (2003)
38. Dumas JJ, R Kumar, J Seehra, WS Somers, L Mosyak: Crystal structure of the GpIbalpha-thrombin complex essential for platelet aggregation. Science. 301, 222-226 (2003)
39. Ramakrishnan V, F DeGuzman, M Bao, SW Hall, LL Leung, DR Phillips: A thrombin receptor function for platelet glycoprotein Ib-IX unmasked by cleavage of glycoprotein V. Proc Natl Acad Sci. 98, 1823-1828 (2001)
40. Sambrano GR, EJ Weiss, YW Zheng, W Huang, SR Coughlin: Role of thrombin signalling in platelets in haemostasis and thrombosis. Nature. 413, 74-78 (2001)
41. Adam F, MC Bouton, MG Huisse, M Jandrot-Perrus: Thrombin interaction with platelet membrane glycoprotein Ib alpha. Trends Mol Med. 9, 461-464 (2003)
42. Sadler JE: Structural biology. A menage a trois in two configurations. Science. 301, 177-179 (2003)
43. Vanhoorelbeke K, H Ulrichts, RA Romijn, EG Huizinga, H Deckmyn: The GPIbalpha-thrombin interaction: far from crystal clear. Trends Mol Med. 10, 33-39 (2004)
44. Adam F, MC Guillin, M Jandrot-Perrus: Glycoprotein Ib-mediated platelet activation. A signalling pathway triggered by thrombin. Eur J Biochem. 270, 2959-2970 (2003)
45. Soslau G, R Class, DA Morgan, C Foster, ST Lord, P Marchese, ZM Ruggeri: Unique pathway of thrombin-induced platelet aggregation mediated by glycoprotein Ib. J Biol Chem. 276, 21173-21183 (2001)
46. Dubois C, B Steiner, N Kieffer, SC Reigner: Thrombin binding to GPIbalpha induces platelet aggregation and fibrin clot retraction supported by resting alphaIIbbeta3 interaction with polymerized fibrin. Thromb Haemost. 89, 853-865 (2003)
47. Jandrot-Perrus M, KJ Clemetson, MG Huisse, MC Guillin: Thrombin interaction with platelet glycoprotein Ib: effect of glycocalicin on thrombin specificity. Blood. 80, 2781-2786 (1992)
48. De Marco L, M Mazzucato, A Masotti, ZM Ruggeri: Localization and characterization of an alpha-thrombin-binding site on platelet glycoprotein Ib alpha. J Biol Chem. 269, 6478-6484 (1994)
49. Esmon CT & P Lollar: Involvement of thrombin anion-binding exosites 1 and 2 in the activation of factor V and factor VIII. J Biol Chem. 271, 13882-13887 (1996)
50. Baglia FA, KO Badellino, CQ Li, JA Lopez, PN Walsh: Factor XI binding to the platelet glycoprotein Ib-IX-V complex promotes factor XI activation by thrombin. J Biol Chem. 277, 1662-1668 (2002)
51. Becker DL, JC Fredenburgh, AR Stafford, JI Weitz: Exosites 1 and 2 are essential for protection of fibrin-bound thrombin from heparin-catalyzed inhibition by antithrombin and heparin cofactor II. J Biol Chem. 274, 6226-6233 (1999)
52. Mendolicchio, G. L., Celikel, R., Varughese, K. I., Savage, B., and Ruggeri, Z. M.: Modulation of von Willebrand Factor A1 Domain-Mediated Platelet Aggregation/Agglutination by alpha-Thrombin. [abstract]. Blood 2004; 104:182aa.
53. Dormann D, KJ Clemetson, BE Kehrel: The GPIb thrombin-binding site is essential for thrombin-induced platelet procoagulant activity. Blood. 96, 2469-2478 (2000)
54. Mazurov AV, DV Vinogradov, TN Vlasik, VS Repin, WJ Booth, MC Berndt: Characterization of an antiglycoprotein Ib monoclonal antibody that specifically inhibits platelet-thrombin interaction. Thromb Res. 62, 673-684 (1991)
55. Lopez JA, RK Andrews, V Afshar Kharghan, MC Berndt: Bernard-Soulier syndrome. Blood 91, 4397-4418 (1998)
56. Meyer SC & JE Fox: Interaction of platelet glycoprotein V with glycoprotein Ib-IX regulates expression of the glycoproteins and binding of von Willebrand factor to glycoprotein Ib-IX in transfected cells. J Biol Chem. 270, 14693-14699 (1995)
57. Calverley DC, M Yagi, SM Stray, GJ Roth: Human platelet glycoprotein V: its role in enhancing expression of the glycoprotein Ib receptor. Blood 86, 1361-1367 (1995)
58. Li CQ, JF Dong, F Lanza, DA Sanan, G Sae-Tung, JA Lopez: Expression of platelet glycoprotein (GP) V in heterologous cells and evidence for its association with GP Ib alpha in forming a GP Ib-IX-V complex on the cell surface. J Biol Chem. 270, 16302-16307 (1995)
59. Ramakrishnan V, PS Reeves, F DeGuzman, U Deshpande, K Ministri-Madrid, RB DuBridge, DR Phillips: Increased thrombin responsiveness in platelets from mice lacking glycoprotein V. Proc Natl Acad Sci. 96, 13336-13341 (1999)
60. Kahn ML, TG Diacovo, DF Bainton, F Lanza, J Trejo, SR Coughlin: Glycoprotein V-deficient platelets have undiminished thrombin responsiveness and Do not exhibit a Bernard-Soulier phenotype. Blood 94, 4112-4121 (1999)
61. Berndt MC & DR Phillips: Purification and preliminary physicochemical characterization of human platelet membrane glycoprotein V. J Biol Chem. 256, 59-65 (1981)
62. Ravanat C, M Morales, DO Azorsa, S Moog, S Schuhler, P Grunert, D Loew, A Van Dorsselaer, JP Cazenave, F Lanza: Gene cloning of rat and mouse platelet glycoprotein V: identification of megakaryocyte-specific promoters and demonstration of functional thrombin cleavage. Blood. 89, 3253-3262 (1997)
63. McGowan EB, A Ding, TC Detwiler: Correlation of thrombin-induced glycoprotein V hydrolysis and platelet activation. J Biol Chem. 258, 11243-11248 (1983)
64. Ware J, S Russell, ZM Ruggeri: Generation and rescue of a murine model of platelet dysfunction: the Bernard-Soulier syndrome. Proc Natl Acad Sci U S A. 97, 2803-2808 (2000)
65. Moog S, P Mangin, N Lenain, C Strassel, C Ravanat, S Schuhler, M Freund, M Sanier, M Kahn, B Nieswandt, C Cachet, JP Cazenave, F Lanza: Platelet glycoprotein V binds to collagen and participates in platelet adhesion and aggregation. Blood 98, 1038-1046 (2001)
66. Ni H, V Ramakrishnan, ZM Ruggeri, JM Papalia, DR Phillips, DD Wagner: Increased thrombogenesis and embolus formation in mice lacking glycoprotein V. Blood 98, 368-373 (2001)
67. Canobbio I, C Balduini, M Torti: Signalling through the platelet glycoprotein Ib-V-IX complex. Cell Signal. 16, 1329-1344 (2004)
68. Azorsa DO, S Moog, C Ravanat, S Schuhler, G Follea, JP Cazenave, F Lanza: Measurement of GPV released by activated platelets using a sensitive immunocapture ELISA-its use to follow platelet storage in transfusion. Thromb Haemost. 81, 131-138 (1999)
69. Ravanat C, M Freund, P Mangin, DO Azorsa, C Schwartz, S Moog, S Schuhler, J Dambach, JP Cazenave, F Lanza: GPV is a marker of in vivo platelet activation-study in a rat thrombosis model. Thromb Haemost. 83, 327-333 (2000)
70. Blann AD, F Lanza, P Galajda, D Gurney, S Moog, JP Cazenave, GY Lip: Increased platelet glycoprotein V levels in patients with coronary and peripheral atherosclerosis - the influence of aspirin and cigarette smoking. Thromb Haemost. 86, 777-783 (2001)
71. Aleil B, JM Mossard, ML Wiesel, F Lanza, JP Cazenave: Increased plasma levels of soluble platelet glycoprotein V in patients with acute myocardial infarction. J Thromb Haemost. 1, 1846-1847 (2003)
72. Morel O, B Hugel, L Jesel, Z Mallat, F Lanza, MP Douchet, M Zupan, M Chauvin, JP Cazenave, A Tedgui, JM Freyssinet, F Toti: Circulating procoagulant microparticles and soluble GPV in myocardial infarction treated by primary percutaneous transluminal coronary angioplasty. A possible role for GPIIb-IIIa antagonists. J Thromb Haemost. 2, 1118-1126 (2004)
73. Kamath S, AD Blann, BS Chin, F Lanza, B Aleil, JP Cazenave, GY Lip: A study of platelet activation in atrial fibrillation and the effects of antithrombotic therapy. Eur Heart J. 23, 1788-1795 (2002)
74. Wolff V, B Aleil, M Giroud, JL Lorenzini, N Meyer, ML Wiesel, JP Cazenave, F Lanza: Soluble Platelet Glycoprotein V Is a Marker of Thrombosis in Patients With Ischemic Stroke. Stroke. (2005), in press.
75. Wu YP, T Vink, M Schiphorst, GH van Zanten, MJ Ijsseldijk, PG de Groot, JJ Sixma: Platelet thrombus formation on collagen at high shear rates is mediated by von Willebrand factor-glycoprotein Ib interaction and inhibited by von Willebrand factor-glycoprotein IIb/IIIa interaction. Arterioscler Thromb Vasc Biol. 20, 1661-1667 (2000)
76. Remijn JA, YP Wu, MJ Ijsseldijk, JJ Zwaginga, JJ Sixma, PG de Groot: Absence of fibrinogen in afibrinogenemia results in large but loosely packed thrombi under flow conditions. Thromb Haemost. 85, 736-742 (2001)
77. Ni H, CV Denis, S Subbarao, JL Degen, TN Sato, RO Hynes, DD Wagner: Persistence of platelet thrombus formation in arterioles of mice lacking both von Willebrand factor and fibrinogen. J Clin Invest. 106, 385-392 (2000)
78. Ni H, PS Yuen, JM Papalia, JE Trevithick, T Sakai, R Fassler, RO Hynes, DD Wagner: Plasma fibronectin promotes thrombus growth and stability in injured arterioles. Proc Natl Acad Sci U S A. 100, 2415-2419 (2003)
79. Wu YP, HJ Bloemendal, EE Voest, T Logtenberg, PG de Groot, MF Gebbink, HC de Boer: Fibrin-incorporated vitronectin is involved in platelet adhesion and thrombus formation through homotypic interactions with platelet-associated vitronectin. Blood. 104, 1034-1041 (2004)
80. Andre P, KS Prasad, CV Denis, M He, JM Papalia, RO Hynes, DR Phillips, DD Wagner: CD40L stabilizes arterial thrombi by a beta3 integrin-dependent mechanism. Nat Med. 8, 247-252 (2002)
81. Kloczewiak M, S Timmons, J Hawiger: Localization of a site interacting with human platelet receptor on carboxy-terminal segment of human fibrinogen gamma chain. Biochem Biophys Res Commun. 107, 181-187 (1982)
82. Ruoslahti E & MD Pierschbacher: New perspectives in cell adhesion: RGD and integrins. Science. 238, 491-497 (1987)
83. Coller BS, K Anderson, HF Weisman: New antiplatelet agents: platelet GPIIb/IIIa antagonists. Thromb Haemost. 74, 302-308 (1995)
84. Farrell DH, P Thiagarajan, DW Chung, EW Davie: Role of fibrinogen alpha and gamma chain sites in platelet aggregation. Proc Natl Acad Sci U S A. 89, 10729-10732 (1992)
85. Zaidi TN, LV Mclntire, DH Farrell, P Thiagarajan: Adhesion of platelets to surface-bound fibrinogen under flow. Blood 88, 2967-2972 (1996)
86. Hettasch JM, MG Bolyard, ST Lord: The residues AGDV of recombinant gamma chains of human fibrinogen must be carboxy-terminal to support human platelet aggregation. Thromb Haemost. 68, 701-706 (1992)
87. Chen CS, SH Chou, P Thiagarajan: Fibrin(ogen) peptide B beta 15-42 inhibits platelet aggregation and fibrinogen binding to activated platelets. Biochemistry. 27, 6121-6126 (1988)
88. Remijn JA, MJ Ijsseldijk, BM van Hemel, DK Galanakis, KA Hogan, KC Lounes, ST Lord, JJ Sixma, PG de Groot: Reduced platelet adhesion in flowing blood to fibrinogen by alterations in segment gamma316-322, part of the fibrin-specific region. Br J Haematol. 117, 650-657 (2002)
89. Briet E & M Peters: The incidence of inhibitors in hemophilia A and the induction of immune tolerance. Adv Exp Med Biol. 489, 89-97 (2001)
90. Rooney MM, DH Farrell, BM van Kernel, PG de Groot, ST Lord: The contribution of the three hypothesized integrin-binding sites in fibrinogen to platelet-mediated clot retraction. Blood. 92, 2374-2381 (1998)
91. Remijn JA, MJ Ijsseldijk, PG de Groot: Role of the fibrinogen gamma-chain sequence gamma316-322 in platelet-mediated clot retraction. J Thromb Haemost. 1, 2245-2246 (2003)
92. Podolnikova NP, VP Yakubenko, GL Volkov, EF Plow, TP Ugarova: Identification of a novel binding site for platelet integrins alpha IIb beta 3 (GPIIbIIIa) and alpha 5 beta 1 in the gamma C-domain of fibrinogen. J Biol Chem. 278, 32251-32258 (2003)
93. Niewiarowski S, S Levy-Toledano, JP Caen: Platelet interaction with polymerizing fibrin in Glanzmann's thrombasthenia. Thromb Res. 23, 457-463 (1981)
94. McGregor L, M Hanss, A Sayegh, JJ Calvette, MC Trzeciak, D Ville, B Catimel, JJ Viala, M Dechavanne, JL McGregor: Aggregation to thrombin and collagen of platelets from a Glanzmann thrombasthenic patient lacking glycoproteins IIb and IIIa. Thromb Haemost. 62, 962-967 (1989)
95. Soslau G & M Favero: The GPIb-thrombin pathway: evidence for a novel role of fibrin in platelet aggregation. J Thromb Haemost. 2, 522-524 (2004)
96. Jarvis GE, BT Atkinson, J Frampton, SP Watson: Thrombin-induced conversion of fibrinogen to fibrin results in rapid platelet trapping which is not dependent on platelet activation or GPIb. Br J Pharmacol. 138, 574-583 (2003)
97. Osdoit, S. and Rosa, J. P.: Polymeric fibrin interacts with platelets independently from integrin alphaIIbbeta3 [abstract]. Blood 98:518aa (2001)
98. Lisman T, J Adelmeijer, HF Heijnen, PG de Groot: Recombinant factor Vila restores aggregation of {alpha}IIb{beta}3-deficient platelets via tissue factor-independent fibrin generation. Blood. 103, 1720-1727 (2004)
99. Poon MC, R d'Oiron, I Hann, C Negrier, L de Lumley, A Thomas, A Karafoulidou, C Demers, A Street, A Huth-Kuhne, P Petrini, E Fressinaud, M Morfini, L Tengborn, A Marques-Verdier, R Musso, O Devecioglu, DS Houston, S Lethagen, C Van Geet, M von Depka, C Berger, P Beurrier, HA Britton, W Gerrits, C Guthner, S Kuhle, JJ Lorenzo, PE Makris, N Nohe, P Paugy, B Pautard, MF Torchet, N Trillot, M Vicariot, J Wilde, M Winter, H Chambost, J Ingerslev, M Peters, G Strauss: Use of recombinant factor Vila (NovoSeven) in patients with Glanzmann thrombasthenia. Semin Hematol. 38, 21-25 (2001)